IL86933A - Method and therapeutic compositions for the prevention of fibrin deposition for adhesions - Google Patents

Method and therapeutic compositions for the prevention of fibrin deposition for adhesions

Info

Publication number
IL86933A
IL86933A IL86933A IL8693388A IL86933A IL 86933 A IL86933 A IL 86933A IL 86933 A IL86933 A IL 86933A IL 8693388 A IL8693388 A IL 8693388A IL 86933 A IL86933 A IL 86933A
Authority
IL
Israel
Prior art keywords
adhesions
prevention
therapeutic compositions
fibrin deposition
fibrin
Prior art date
Application number
IL86933A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to IL102625A priority Critical patent/IL102625A0/xx
Publication of IL86933A publication Critical patent/IL86933A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL86933A 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition for adhesions IL86933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL102625A IL102625A0 (en) 1987-07-01 1992-07-23 Dispensing device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US12531987A 1987-11-25 1987-11-25
US21089588A 1988-06-24 1988-06-24

Publications (1)

Publication Number Publication Date
IL86933A true IL86933A (en) 1993-07-08

Family

ID=27371438

Family Applications (2)

Application Number Title Priority Date Filing Date
IL86933A IL86933A (en) 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
IL102625A IL102625A0 (en) 1987-07-01 1992-07-23 Dispensing device

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL102625A IL102625A0 (en) 1987-07-01 1992-07-23 Dispensing device

Country Status (14)

Country Link
EP (1) EP0297860B1 (no)
JP (1) JP2756131B2 (no)
KR (1) KR0131330B1 (no)
AU (1) AU621305B2 (no)
DE (1) DE3883645T2 (no)
DK (1) DK175597B1 (no)
FI (1) FI103868B1 (no)
IE (1) IE65658B1 (no)
IL (2) IL86933A (no)
NO (1) NO301748B1 (no)
NZ (1) NZ225260A (no)
PH (1) PH26527A (no)
PT (1) PT87886B (no)
WO (1) WO1989000049A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1995001292A1 (en) * 1993-07-02 1995-01-12 Quest International Bv. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
WO1999024062A1 (en) * 1997-11-07 1999-05-20 Chiron Corporation Novel igf-i composition and its use
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator

Also Published As

Publication number Publication date
NZ225260A (en) 1991-03-26
DE3883645T2 (de) 1994-02-03
KR0131330B1 (ko) 1998-04-17
NO895338D0 (no) 1989-12-29
WO1989000049A1 (en) 1989-01-12
AU621305B2 (en) 1992-03-12
PT87886B (pt) 1993-09-30
IE882023L (en) 1989-01-01
DK175597B1 (da) 2004-12-13
KR890701124A (ko) 1989-12-19
DE3883645D1 (de) 1993-10-07
FI103868B (fi) 1999-10-15
JP2756131B2 (ja) 1998-05-25
EP0297860B1 (en) 1993-09-01
DK675389D0 (da) 1989-12-29
NO301748B1 (no) 1997-12-08
PH26527A (en) 1992-08-07
FI103868B1 (fi) 1999-10-15
DK675389A (da) 1990-02-28
JPH04502753A (ja) 1992-05-21
PT87886A (pt) 1989-06-30
AU1998588A (en) 1989-01-30
FI896359A0 (fi) 1989-12-29
IE65658B1 (en) 1995-11-15
NO895338L (no) 1990-02-28
EP0297860A1 (en) 1989-01-04
IL102625A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
AU2260088A (en) Methods and compositions for the treatment of lung conditions
AU4032989A (en) Method and compositions for the treatment and prevention of septic shock
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
EP0165754A3 (en) Treatment of refractory articles
IL88205A0 (en) Novel pyridine compounds and compositions for the treatment of osteoporosis
JPS6468481A (en) Phosphate treatment of metal
AU1520188A (en) Compositions and methods of treatment of timber
IL86933A (en) Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
AU591199B2 (en) Method for the treatment and prevention of epithelial destruction
AU3189989A (en) Process for the treatment of concrete
EP0185283A3 (en) Use of dihydropyridines for the treatment and prevention of arteriosclerosis
ZA884739B (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
HUT46733A (en) Composition and process for cleaning of fuel equipments from the fire-side
HU8905409D0 (en) Process for the preparation of compositions containing ace inhibitor suitable for the treatment of postischaemic cardiac disturbances
AU1541088A (en) Composition for the treatment of the epiderm
GB2239412B (en) Methods of treating surfaces
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
GB8700950D0 (en) Treatment of super-alloy surfaces
ZA889130B (en) Compositions for the reduction of phlebectasiae and process for preparing same
AU2473388A (en) Treatment of factor viii inhibitors
ZA855613B (en) Composition and method for the treatment of hemorrhoids
IL93901A0 (en) Intranasal compositions for the administration of physo-stigmine and arecoline

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
KB Patent renewed
EXP Patent expired